期刊文献+

产超广谱β-内酰胺酶大肠埃希菌的分离率与抗菌药物消耗量相关性研究 被引量:2

A Study of Relationships Between Isolation of Extended-spectrum β-lactamases-producing Escherichia coli and Antimicrobial Consumption
下载PDF
导出
摘要 目的了解产超广谱β-内酰胺酶大肠埃希菌的分离率与抗菌药物消耗量之间的关系。方法:统计2000~2004年各类抗菌药物的年消耗量及产超广谱β-内酰胺酶(ESBLs)大肠埃希菌的分离率,采用多元线性回归对消耗量与分离率进行分析。结果:5年来含β-内酰胺酶抑制剂复合制剂的消耗量大幅上升;第2~4代头孢菌素处于上升期,以第4代升幅最大。喹诺酮类用量虽有所波动,但总体呈下降趋势。氨基糖苷类、磺胺类、酰胺醇类用量呈萎缩状态。大肠埃希菌产ESBLs阳性率逐年上升。产ESBLs大肠埃希菌的分离率与第3代头孢菌素、磺胺类、氟喹诺酮类、多肽类的消耗量有显著线性依存关系。结论:为防止产ESBLs大肠埃希菌的局部流行,提示临床使用抗菌药物应更具合理性。 Objective To study the relationships between isolation of ESBLs-producing Escherichia coh(E.coN) and antimicrobial consumption. Methods: The consumption of diferent kinds of antimicrobial agents that administered to inpatients during 2000-2004 and isolation of ESBLs-producing E.coli were collected retrospectively. The correlation between the isolation and antimicrobial consumption were analyzed using multiple linear regression, Results: The use of compound β -lactamase inhibitors and second- to fourth-generation cephalosporins significantly increased during the study period, in contrast to a decreased consumption for fluoroquinolones, aminoglycosides, sulfonamides and amphenicols. Isolation of ESBLs-producing E.coli appeared increasing tendency. A statistically significant association existed between isolation of ESBLs-producing E.coli and consumption of third-generation cephalosporins, sulfonamides, fluoroctuinolones, polypeption. Conclusion In order to prevent the ESBLs-producing E.coli infection outbreak, it suggested that antibiotics be used rationally.
出处 《医药世界》 2006年第5期58-60,共3页 Medicine World
关键词 大肠埃希菌 抗菌药物 超广谱Β-内酰胺酶 消耗量 Escherichia coil, Antimicrobial, Extended-spectrum β-lactamases,Consumption
  • 相关文献

参考文献3

二级参考文献12

  • 1National Committee for Clinical Laboratory Standard 2002. Performance standards for antimicrobial susceptibility testing [S]. NCCLS, Wayne, Pa M2-A7 and MT-AS. 2OO2.
  • 2Winokur P L, Canton R, Casellas J M, et al. Variations in the prevalence of strains expressing an extended-speectrum β-lactamases phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region [J]. Clin Infect Dis,2001,32(Suppl 2):s94.
  • 3朱德妹 熊自忠 胡付品.上海地区医院临床分离革兰阴性杆菌中ESBLs的研究[A]..中国细菌耐药与抗感染化疗研究进展[M].北京:中华医学电子音像出版社,2002.55.
  • 4Palucha A, Mikiewicz B, Hryniewicz W, et al. Concurrent outbreaks of extended-spectrum β-lactamases-producing organisms of the family Enterobacteriaceae in a Warsaw hospital [J]. J Antimicrob Chemother, 1999,44 (4) : 489.
  • 5Champs C D, Sirot D, Chanal C, et al. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France [J]. Antimicrob Agents Chemother, 2000,44 (11 ) :3177.
  • 6Spanu T, Luzzaro F, Perilli M, et al. Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy : implications for resistance to β-lactams and other antimicrobial drugs [J]. Antimicrob Agents Chemother, 2002,46 (1) : 196.
  • 7汪复.革兰阴性杆菌对β-内酰胺类的耐药性及其防治[J].中华传染病杂志,2000,18(3):207-210. 被引量:64
  • 8吴伟元,陈民钧,王辉.阴沟肠杆菌去阻遏持续高产AmpC酶和超广谱β-内酰胺酶(ESBLs)的检测[J].中国临床药理学杂志,2001,17(2):104-109. 被引量:201
  • 9佘丹阳,刘又宁.AmpC酶和超广谱β-内酰胺酶在阴沟肠杆菌中的表达及对其耐药性的影响[J].中华医学杂志,2002,82(19):1355-1358. 被引量:86
  • 10李家泰,李耘,王进,中国细菌耐药监测研究组.中国医院和社区获得性感染革兰阳性球菌耐药性监测研究[J].中华医学杂志,2003,83(5):365-374. 被引量:198

共引文献51

同被引文献9

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部